An open-label trial in 2050 elderly outpatients with depression treated with escitalopram in a naturalistic setting in Germany

被引：0
|
作者：
Moeller, H.-J. [1 ]
Schnitker, J. [2 ]
Fluerenbrock, W. [3 ]
Fuger, J. [4 ]
机构：
[1] Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[2] Inst Angew Stat GmbH, Bielefeld, Germany
[3] Lundbeck GmbH, Sci Unit, Hamburg, Germany
[4] Lundbeck GmbH, Med Affairs, Hamburg, Germany
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [21] Risperidone in elderly schizophrenic patients - An open-label trial
    Berman, I
    Merson, A
    RachovPavlov, J
    Allan, E
    Davidson, M
    Losonczy, MF
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1996, 4 (02): : 173 - 179
  • [22] Open-label trial of nefazodone for depression in CHF patients
    Lespérance, F
    Frasure-Smith, N
    PSYCHOSOMATIC MEDICINE, 2001, 63 (01): : 163 - 164
  • [23] What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label study
    Shim, Geumsook
    Park, Hye Youn
    Jang, Joon Hwan
    Kim, Euitae
    Park, Hye Yoon
    Hwang, Jae Yeon
    Kim, Sung Nyun
    Jang, Go-Eun
    Kwon, Jun Soo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (05) : 284 - 290
  • [24] A large, open-label trial of nimesulide in patients with osteoarticular conditions treated in a general practice setting
    Famaey, JP
    Vandekerckhove, K
    Geczy, J
    Bruhwyler, J
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (07): : 467 - 482
  • [25] An open-label study of Escitalopram (Lexapro®) for the treatment of 'Depression of Alzheimer's disease' (dAD)
    Rao, V
    Spiro, JR
    Rosenberg, PB
    Lee, HB
    Rosenblatt, A
    Lyketsos, CG
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (03) : 273 - 274
  • [26] Comparative efficacy and safety of escitalopram versus desvenlafaxine in postmenopausal women with depression and anxiety: A randomized, open-label, comparative trial
    Mahajan, Sonia Shinde
    Tandon, Vishal R.
    Arora, Manu
    Mahajan, Annil
    Kotwal, Suman
    JOURNAL OF MID-LIFE HEALTH, 2019, 10 (03) : 141 - 146
  • [27] An open-label trial of escitalopram in the treatment of impulsive-compulsive internet usage disorder
    Dell'Osso, B
    Altamura, AC
    Hadley, SJ
    Baker, BR
    Hollander, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S82 - S83
  • [28] Escitalopram treatment of kleptomania: An open-label trial followed by double-blind discontinuation
    Koran, Lorrin M.
    Aboujaoude, Elias N.
    Gamel, Nona N.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (03) : 422 - 427
  • [29] Duloxetine treatment of dysthymia and double depression: an open-label trial
    Koran, Lorrin M.
    Aboujaoude, Elias N.
    Gamel, Nona N.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 761 - 765
  • [30] Effects of Bupropion Augmentation in Escitalopram-Resistant Patients With Major Depressive Disorder: An Open-Label, Naturalistic Study
    Maron, Eduard
    Eller, Triin
    Vasar, Veiko
    Nutt, David J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (07) : 1054 - 1056
12345